NCT02687997

Completed

Prevalence of Sleep Disordered Breathing in a Lung Cancer Sc...

Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz Source

Compare

Other study identifiers

Sponsor study identifier

InsitutoFJD

Study Type

interventional

Actual enrollment (reported)

282

Locations

1 country

Sites

1

Timeline

Study Start

February 2016

Date type not reported

This date has not been verified as actual or estimated.

Primary Completion

July 31, 2017

Actual (reported)

Study Completion

July 31, 2017

Actual (reported)

Brief Summary

Prospective study of sleep disordered breathing in a lung cancer screening cohort.

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: completed
Actual enrollment (reported): 282 participants
Study completion date: July 31, 2017
Actual (reported)
Listed locations: 1 countries · 1 sites

Trial Relationships

Click on a node to explore related trials.

Some registry-reported names shown below are not yet linked in this graph.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

Study Start
February 2016
Date type not reported
This date has not been verified as actual or estimated.
First Submitted
February 17, 2016
Actual (reported)
First Posted
February 23, 2016
Actual (reported)
Primary Completion
July 31, 2017
Actual (reported)
Study Completion
July 31, 2017
Actual (reported)

Last Updated: September 11, 2017
Status Verified: September 2017
Last Update Submitted: September 7, 2017

Conditions

COPD Emphysema Lung Cancer Sleep Apnea Hypopnea Syndrome

Outcome Measures

Primary Outcomes (1)

Prevalence of sleep apnea
1 year

Study Arms (2)

Diagnostic

EXPERIMENTAL

Patients enrolled in lung cancer screening subjected to a sleep study.

Other: poligraphy

Contro

NO INTERVENTION

Patients enrolled in lung cancer screening not included in the diagnostic intervention arm

Interventions

poligraphyOther

Sleep study

Diagnostic

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age55 Years - 75 Years

Sexall

Healthy VolunteersYes

Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

Age 55-75.
\> 30 pack years tobacco exposure.

Sponsors & Collaborators

Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
Otherlead

Study Sites (1)

Fundacion Jimenez Diaz

Madrid, 28040, Spain

MeSH Terms

Conditions

Sleep Apnea, ObstructivePulmonary Disease, Chronic ObstructiveEmphysemaLung Neoplasms

Condition Hierarchy (Ancestors)

Sleep Apnea SyndromesApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesLung Diseases, ObstructiveLung DiseasesChronic Disease

Enrollment

282 participants (actual enrollment reported by the registry).

Study Design

Study Type: interventional
Phase: not applicable
Allocation: NON RANDOMIZED
Masking: NONE
Purpose: DIAGNOSTIC
Intervention Model: SINGLE GROUP
Sponsor Type: OTHER
Responsible Party: PRINCIPAL INVESTIGATOR
PI Title: Attending Physician

Study Record Dates

First Submitted

February 17, 2016

First Posted

February 23, 2016

Study Start

February 2016

Date type not reported

This date has not been verified as actual or estimated.

NCT02823223

Endobronchial Valve in Patients With Heterogeneous Emphysema

Not ApplicableUnknown

NCT01949181

Blood, Hair and Lung Concentrations of Metals and Metalloids in Patients With Lung Cancer or Chronic Obstructive Pulmonary Disease

Not ApplicableCompleted

NCT03814980

A Home-based Intervention to Promote Mindful Breathing Awareness Through Pursed-lip Breathing Training for COPD Patients

Not ApplicableCompleted

NCT03060915

Actigraphy Sleep Parameters in Obstructive Sleep Apnea Patient's

Not ApplicableCompleted

NCT02121379

Randomized Clinical Trial of 8 Weeks Pulmonary Rehabilitation in Advanced Stage Lung Cancer Patients With COPD During Cytotoxic Chemotherapy

Not ApplicableUnknown

NCT02935452

Implementing and Evaluating the Genie Tool in COPD

Not ApplicableCompleted

Enrolled in lung cancer screening program.

You may not qualify if:

Inability or unwillingness to undergo a home sleep study.

Contact the study team to confirm eligibility.

Disease Attributes

Pathologic Processes

Pathological Conditions, Signs and Symptoms

Respiratory Tract Neoplasms

Thoracic Neoplasms

Neoplasms by Site

Neoplasms

Primary Completion

July 31, 2017

Actual (reported)

Study Completion

July 31, 2017

Actual (reported)

Last Updated

September 11, 2017

Record last verified: 2017-09

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT02687997
Data provider: ClinicalTrials.gov
Source updated: 2017-09-11
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:24:52 UTC

Locations

ES(1)

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Outcome Measures

Primary Outcomes (1)

Study Arms (2)

Diagnostic

Contro

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations